1. Comorbidity between depression and asthma via immune-inflammatory pathways: A meta-analysis
   Mingdi Jiang et al, 2014, Journal of Affective Disorders CrossRef
2. Imbalance of tumor necrosis factor-α, interleukin-8 and interleukin-10 production evokes barrier dysfunction, severe abdominal symptoms and psychological disorders in patients with irritable bowel syndrome-associated diarrhea
   YANBO ZHEN et al, 2015 CrossRef
3. Personality traits and emotional patterns in irritable bowel syndrome
   Maria Rosaria A Muscatello et al, 2016, WJG CrossRef
4. Effect of combined consumption of Lactobacillus brevis KB290 and β-carotene on minor diarrhoea-predominant irritable bowel syndrome-like symptoms in healthy subjects: a randomised, double-blind, placebo-controlled, parallel-group trial
   Nobuo Fuke et al, 2017, International Journal of Food Sciences and Nutrition CrossRef
5. The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis.
   Changhyun Lee et al, 2017, J Neurogastroenterol Motil CrossRef
6. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review
   Grace Burns et al, 2018, Am J Gastroenterol CrossRef
7. Expression of immune-related genes in rectum and colon descendens of Irritable Bowel Syndrome patients is unrelated to clinical symptoms
   Javier Aguilera-Lizarraga et al, 2019, Neurogastroenterology & Motility CrossRef
8. Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy
   Shakuntla Gondalia et al, 2019, Psychopharmacology CrossRef
9. The mucosal immune system: master regulator of bidirectional gut–brain communications
   Nick Powell et al, 2017, Nat Rev Gastroenterol Hepatol CrossRef
10. Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses
    Irina Midenfjord et al, 2019, Neurogastroenterology & Motility CrossRef
11. Chemotactic Chemokines Are Important in the Pathogenesis of Irritable Bowel Syndrome
    Charles Darkoh et al, 2014, PLoS ONE CrossRef
12. Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis
    M. Bashashati et al, 2014, Neurogastroenterol. Motil. CrossRef
13. Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators
    Juan J Martin-Viñas et al, 2016, Journal of Digestive Diseases CrossRef
14. Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome
    Sunil Kumar et al, 2017, Clinical Therapeutics CrossRef
15. Acupuncture treatment for depressive symptom in diarrhea-predominant irritable bowel syndrome: a randomized controlled study
    Guo-juan Meng, 2019, J. Acupunct. Tuina. Sci. CrossRef
16. Potential neuro-immune therapeutic targets in irritable bowel syndrome
    Maite Casado-Bedmar et al, 2020, Therap Adv Gastroenterol CrossRef
17. Activating metabotropic glutamate receptor‑7 attenuates visceral hypersensitivity in neonatal maternally separated rats
    Limei Shao et al, 2018, Int J Mol Med CrossRef
18. Is there a causal link between psychological disorders and functional gastrointestinal disorders?
    Natasha Koloski et al, 2020, Expert Review of Gastroenterology & Hepatology CrossRef
19. Cytokines in the colon, central nervous system and serum of irritable bowel syndrome rats
    Guanqun Chao et al, 2021, Eur J Med Res CrossRef
20. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
    Dipesh H Vasant et al, 2021, Gut CrossRef
21. Electroencephalographic evidence of unconscious and conscious attentional bias in people with functional gastrointestinal disorders: A pilot study
    Anastasia Ejova et al, 2021, International Journal of Psychophysiology CrossRef
22. The specifics of emotional dysregulation in women with various types of irritable bowel syndrome
    Aleksey I. Melehin, 2022, Neurology bulletin CrossRef
23. Small Intestine Bacterial Overgrowth Can Form an Indigenous Proinflammatory Environment in the Duodenum: A Prospective Study
    Evripidis Rizos et al, 2022, Microorganisms CrossRef
24. Heart Rate Variability—An Index of the Efficacy of Complementary Therapies in Irritable Bowel Syndrome: A Systematic Review
    Magdalena Mróz et al, 2022, Nutrients CrossRef
25. The Immune Phenotype of Perinatal Anxiety
    Morgan L. Sherer et al, 2022, Brain, Behavior, and Immunity CrossRef
26. Biological Mechanisms in Pregnant Women with Anxiety (Happy Mother-Healthy Baby Supplement Study): Protocol for a Longitudinal Mixed Methods Observational Study (Preprint)
    Morgan L. Sherer et al, 2022 CrossRef
27. The Microbiota–Gut–Brain Axis: Psychoneuroimmunological Insights
    Giuseppe Marano et al, 2023, Nutrients CrossRef
28. A review of cytokine-based pathophysiology of Long COVID symptoms
    Russell N. Low et al, 2023, Front. Med. CrossRef
29. Causal association between psycho-psychological factors, such as stress, anxiety, depression, and irritable bowel syndrome: Mendelian randomization.
    Zhihao Diao et al, 2023, Medicine (Baltimore) CrossRef
30. Comorbidities
    Hideki Mori et al, 2024 CrossRef